Donanemab in early Alzheimer’s disease MA Mintun, AC Lo, C Duggan Evans, AM Wessels, PA Ardayfio, ... New England Journal of Medicine 384 (18), 1691-1704, 2021 | 1171 | 2021 |
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ... Jama 330 (6), 512-527, 2023 | 1084 | 2023 |
Impaired visual search in drivers with Parkinson's disease EY Uc, M Rizzo, SW Anderson, JD Sparks, RL Rodnitzky, JD Dawson Annals of neurology 60 (4), 407-413, 2006 | 213 | 2006 |
Clinical relevance of fatigue as a residual symptom in major depressive disorder M Fava, S Ball, JC Nelson, JD Sparks, T Konechnik, P Classi, S Dube, ... Depression and anxiety 31 (3), 250-257, 2014 | 185 | 2014 |
Impaired navigation in drivers with Parkinson's disease EY Uc, M Rizzo, SW Anderson, JD Sparks, RL Rodnitzky, JD Dawson Brain 130 (9), 2433-2440, 2007 | 170 | 2007 |
Driving with distraction in Parkinson disease EY Uc, M Rizzo, SW Anderson, JD Sparks, RL Rodnitzky, JD Dawson Neurology 67 (10), 1774-1780, 2006 | 156 | 2006 |
Driving under low-contrast visibility conditions in Parkinson disease EY Uc, M Rizzo, SW Anderson, E Dastrup, JD Sparks, JD Dawson Neurology 73 (14), 1103-1110, 2009 | 125 | 2009 |
Visual vigilance in drivers with obstructive sleep apnea J Tippin, JD Sparks, M Rizzo Journal of psychosomatic research 67 (2), 143-151, 2009 | 54 | 2009 |
Change blindness, aging, and cognition M Rizzo, JD Sparks, S McEvoy, S Viamonte, I Kellison, SP Vecera Journal of Clinical and Experimental Neuropsychology 31 (2), 245-256, 2009 | 54 | 2009 |
Bimodal ultradian seizure periodicity in human mesial temporal lobe epilepsy M Karafin, EKS Louis, MB Zimmerman, JD Sparks, MA Granner Seizure 19 (6), 347-351, 2010 | 50 | 2010 |
‘Time saved’as a demonstration of clinical meaningfulness and illustrated using the donanemab TRAILBLAZER-ALZ study findings SP Dickson, AM Wessels, SA Dowsett, C Mallinckrodt, JD Sparks, ... The journal of prevention of Alzheimer's disease 10 (3), 595-599, 2023 | 25 | 2023 |
Statistical properties of continuous composite scales and implications for drug development H Liu-Seifert, S Andersen, M Case, JD Sparks, KC Holdridge, ... Journal of biopharmaceutical statistics 27 (6), 1104-1114, 2017 | 24 | 2017 |
Further evidence for the reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ) L Baer, S Ball, JD Sparks, J Raskin, S Dubé, M Ferguson, M Fava , 26, 4 26 (4), 270-281, 2014 | 20 | 2014 |
A statewide outbreak of Cryptosporidium and its association with the distribution of public swimming pools PM Polgreen, JD Sparks, LA Polgreen, M Yang, ML Harris, MA Pentella, ... Epidemiology & Infection 140 (8), 1439-1445, 2012 | 17 | 2012 |
First and second-order motion perception after focal human brain lesions M Rizzo, M Nawrot, JD Sparks, J Dawson Vision research 48 (26), 2682-2688, 2008 | 13 | 2008 |
Change blindness, attention, and driving performance MN Lees, JD Sparks, JD Lee, M Rizzo Driving Assessment Conference 4 (2007), 2007 | 13 | 2007 |
Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial M Mintun, CW Ritchie, P Solomon, JR Sims, S Salloway, O Hansson, ... Alzheimer's & Dementia 19, e082733, 2023 | 10 | 2023 |
APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials CD Evans, JD Sparks, SW Andersen, DA Brooks, PM Hauck, MA Mintun, ... Alzheimer's & Dementia 19 (12), 5407-5417, 2023 | 10 | 2023 |
Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin … SG Ball, MB Ferguson, JM Martinez, BA Pangallo, ESM Nery, MA Dellva, ... The Journal of Clinical Psychiatry 77 (5), 6079, 2016 | 10 | 2016 |
Long-term, open-label, safety study of edivoxetine 12 to 18 mg once daily as adjunctive treatment for patients with major depressive disorder who are partial responders to … SG Ball, S Atkinson, JD Sparks, M Bangs, C Goldberger, S Dubé Journal of Clinical Psychopharmacology 35 (3), 266-272, 2015 | 9 | 2015 |